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A b s tract
Benzodiazepines are often used for the treatment of epilepsy,
convulsions, and many psychiatric disorders. The widespread use
of this class of drugs has occasionally raised concern about
recreational benzodiazepine abuse and has led to the erroneous
impression that benzodiazepines have a relatively high abuse
liability among recreational drug users. Therefore, the separation
and identification of these compounds is of great interest. In
general, the separation of benzodiazepines is performed using highperformance liquid chromatography (HPLC). Recently, capillary
electrochromatography, which combines the high efficiency of
capillary zone electrophoresis and the high selectivity of HPLC, has
gained much attention. The focus of the work reported here is the
use of a 40-cm packed bed of Reliasil 3-µm C 18 stationary phase to
separate seven benzodiazepines. Optimal conditions are established
by varying the mobile phase, amount of organic modifier, buffer
concentration, applied voltage, and column temperature. A mobile
phase composition of Tris-HCl (pH 8)–acetonitrile (60:40), an
electrolyte concentration of 30mM, and a temperature of 15°C with
an applied voltage of 20 kV proves to be optimum. In addition, the
method developed here is applied to the characterization of
oxazepam in a standard urine sample.

Introduction
Benzodiazepines are extremely safe and effective medicinal
compounds that are used primarily for the treatment of anxiety
and sleep disorders (1). In fact, these drugs are among the most
widely prescribed of all psychoactive drugs. They are of considerable importance in forensic toxicology having hypnotic, tranquillizing, and anticonvulsant pro p e rties; thus, they are often
encountered in casework involving road traffic offences or drug
o v e rdose (2–4). They enter the brain rapidly and work by binding
to a specific type of receptor protein, which is widely distributed
in groups of nerve cells involved in anxiety, memory, sedation,
and coordination. In recent years, there has been a gro w i n g
interest regarding the side effects of benzodiazepines. These
e ffects include dizziness, adverse interaction with alcohol, and
* Author to whom correspondence should be addressed: e-mail iwarner@lsu.edu.
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risk of dependence after long-term use (5). For these reasons, the
analysis of such compounds is vital to areas such as pharmaceutical analysis, therapeutic drug monitoring, and forensic toxicology (6–8). A variety of methods have been developed for the
separation of benzodiazepines, but only some of them have been
applied to their identification and determination in complex
matrices such as blood (9–21), urine (22–27), and hair (28,29).
The methods most frequently used for controlling and monitoring these drugs in blood or urine are voltametry (30,31),
radioimmunoassay (6,15), spectrophotometry (32), supercritical
fluid chromatography (33), thin-layer chromatography (25,34),
gas chromatography (GC) (10,11,26–28), and high-performance
liquid chromatography (HPLC) (2,16–21,34–38). Among these
techniques, GC and HPLC have been the most popular because of
their selectivity. However, GC analysis is complicated and time
consuming because of the need for derivatization and the thermal
instability of some drugs, such as oxazepam (39). According to the
literature, the separation of benzodiazepines is mainly performed
by liquid chromatography (LC) using reversed-phase systems
composed of silica support materials and chemically bonded alkyl
chains (octyl or octadecyl) (2,34). In comparison with existing
e l e c t rokinetic techniques, such as capillary zone electrophoresis
(CZE) and micellar electrokinetic chromatography (MEKC),
HPLC has low column efficiency because of the need for pressuredriven flow.
CZE and MEKC are well established for the separation of many
classes of compounds. However, CZE is unable to resolve benzodiazepines because the majority of them are neutral and of similar hydrophobicity. MEKC has been proposed as an alternative
a p p roach, by which micelles are introduced into the background
e l e c t rolyte and the separation of some neutral species is achieved
(40,41). MEKC has been successfully used to separate benzodiazepines (13,22–24,39,42). Boonkerd et al. (42) have studied the
migration behavior of a series of benzodiazepines in MEKC using
t h ree kinds of surfactants [i.e., sodium dodecyl sulfate (SDS),
dodecyl trimethylammonium bromide (DoTAB), and bile salts].
Renou-Gonnord and David (39) have studied the effects of SDS,
β-cyclodextrin, urea, organic solvents, and applied voltage on the
separation of nine benzodiazepines using MEKC. Although easy
to implement, MEKC lacks the selectivity and variety of stationary
phases that HPLC offers (43,44). Another disadvantage of MEKC

Reproduction (photocopying) of editorial content of this journal is prohibited without publisher’s permission.

Downloaded from https://academic.oup.com/chromsci/article/42/5/238/352794 by Louisiana State University user on 01 December 2021

Separation of Benzodiazepines Using Capillary
Electrochromatography

Journal of Chromatographic Science, Vol. 42, May/June 2004

Experimental
Reagents and chemicals

Oxazepam, lorazepam, nitrazepam, clonazepam, temazepam,
flunitrazepam, diazepam, and t r i s(hydroxymethyl)aminomethane-hydrochloride (Tris-HCl) were purchased from Sigma
Chemical (St Louis, MO). Acetonitrile (ACN), methanol (MeOH),
and tetrahydrofuran (THF) were obtained from Fisher
(Springfield, NJ). Hydrochloric acid was purchased fro m
Mallinckrodt & Baker (Paris, KY). Polyimide-coated fused-silica
capillary columns of 100-µm i.d. × 365-µm o.d. were obtained
f rom Polymicro Technologies (Phoenix, AZ). The columns were
packed with a 3-µm Reliasil CEC C18 stationary phase that was
p u rchased from Column Engineering (Ontario, CA). The DAT
multidrug high urine calibrator was donated by the Earl K. Long
Hospital (Baton Rouge, LA).
Instrumentation and conditions

The CEC experiments re p o rted here were conducted using an
HP3DCE CE system (Agilent Technologies, Wilmington, DE).
Data were collected using HP3DCE Chemstation software (Agilent
Technologies). The dimensions of the capillary were 48-cm × 100µm i.d. (40 cm to the detector). All CEC separations were perf o rmed by pressurizing both the inlet and outlet buffer vials with

12 bar of nitrogen to prevent bubble formation. Unless stated othe rwise, the temperature of the capillary cassette was maintained
at 25ºC by the instrument thermostating system. Detection of the
analytes was perf o rmed using a photodiode array detection
system set to 220 nm. All sample solutions were injected elect rokinetically (15 kV for 5 s).
Sample and buffer preparation

Analytical standard benzodiazepine stock solutions were prep a red at concentrations of 2 mg/mL in MeOH. A 400-µL aliquot of
each analyte was mixed, and the final concentration of each benzodiazepine in the test mixture was approximately 0.3 mg/mL. A
b u ffer solution of 100mM Tris was pre p a red by dissolving the
a p p ropriate amount of Tris buffer in 10 mL of deionized water,
and the pH was adjusted to 8.0 using 1M HCl. An appropriate percentage of ACN, MeOH, or THF (v/v) was added to an appropriate
p e rcentage of the aqueous Tris buffer solution (v/v), and then the
final volume was adjusted with deionized water depending on the
mobile phase being studied. The final solution was filtered using
a polypropylene nylon filter with 0.45-µm pore size and sonicated
for 15 min. Finally, the urine sample was injected into the CEC
capillary without any preparation.
Preparation and conditioning of packed capillary columns

The CEC columns were packed in our laboratory according to a
s t a n d a rd pro c e d u re developed elsewhere (54,55). The 3-µm
Reliasil CEC C18 silica stationary phase was slurried in acetone at
a concentration of 0.2 g/mL. After sonication, 1 mL of slurry was
injected through a Rheodyne injector connected to a stainless
steel reservoir. The injector was connected to the Knauer pneumatic HPLC pump (Berlin, Germany), and the slurry reservoir
was connected to the capillary. The other end of the capillary was
connected to a union containing a 0.5-µm frit. The pump pre ss u re was set to 400 bar. When the capillary was filled with stationary phase, the pump was turned off and the excess slurry was
removed from the reservoir. The capillary was reconnected, and
the pump was set back to 400 bar for two more hours. While the
pump was on, the first frit was fabricated using an electrically
heated Nichrome wire. The bottom union from the capillary was
removed, and the excess stationary phase was flushed out with
200 bar pump pressure. The last procedure was repeated after the
preparation of the second frit. The detection window was placed
adjacent to the outlet frit by burning off the polyimide coating.
The packed capillary column was flushed with the mobile phase
for 1 h and then installed in a capillary cartridge. The column was
f u rther conditioned by applying both pre s s u re of 12 bar to the
inlet side and potential in 5 kV increments for 10 min up to 25 kV.
Finally, both the inlet and oulet vials were pressurized, and the
voltage was set to 30 kV until the current was stabilized. This procedure was used whenever a new mobile phase was tested.
Between injections, the CEC columns were conditioned for 5 min
using 10 kV.

Results and Discussion
The chemical stru c t u res and numerical designations for each
of the seven benzodiazepines used in this study are shown in
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is its incompatibility with mass spectrometry detection because of
the high concentrations of surfactants used (45).
The CEC method is an alternative approach to MEKC. It uses a
stationary phase rather than a micellar pseudostationary phase.
Solutes are separated according to their partitioning between the
mobile and stationary phase and, when charged, their elect ro p h o retic mobility (46,47). Thus, CEC is a hybrid technique
that combines the selectivity of HPLC and separation efficiency of
capillary electro p h o resis (CE). The mobile phase in CEC is driven
by electroosmotic flow (EOF) induced by applying an electrical
field over the column (45). The advantages that CEC offers over
HPLC include higher efficiency, the possibility of using small particles in beds that would create high back pressure in HPLC, and
the unique selectivity because of the superimposition of chromatographic and electro p h o retic effects (48).
The method of CEC has been successfully used for the analysis
of neutral drugs (49–51). However, only a few studies have been
p e rf o rmed on the separation of benzodiazepines using CEC
(44,45,52,53). Cahours et al. (45) have investigated the influence
of temperature, ionic strength, and organic modifier content on
electrophoretic, chromatographic, and separation performances
of five benzodiazepines using CEC on a phenyl-bonded silica
column. Jinno et al. (52) have compared the separation behavior
of a series of benzodiazepines in packed CEC and open-tubular
CEC using a cholesteryl silica-bonded phase.
The study re p o rted here describes the influence of several
experimental parameters to obtain improved selectivity and eff iciency for the separation of seven benzodiazepine standards using
CEC by use of an octadecyl silica (ODS) stationary phase. The
optimized method proved to be effective in characterizing
oxazepam in a urine sample.
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F i g u re 1. The influence of operating parameters, such as nature
and amount of organic modifier, buffer electrolyte concentration,
applied voltage, and temperature, were studied to optimize the
CEC separation of these benzodiazepines.

(10mM). A pH of 8 was chosen because the EOF at this pH had a
greater stability, and the analysis time was shorter as compared
with lower pH values.
For a given capillary, the EOF (meo) is defined as:

Effect of the nature of organic modifier

meo = LdLt /Vto

Figure 1. Structures of the seven benzodiazepine analytes.

Figure 2. Effect of the nature of organic modifier on the CEC separation of
benzodiazepines. Conditions: C18 stationary phase, 40 cm packed × 100-µm
i.d.; electrolyte, 10mM Tris (pH 8)–ACN (40:60), 10mM Tris (pH 8)–MeOH
(30:70), and 10mM Tris (pH 8)–THF (55:45); applied voltage, 30 kV;
electrokinetic injection, 15 kV for 5 s; temperature, 25°C; and UV detection,
220 nm.
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Eq. 1

where Ld is the distance from injector to detector, Lt is the total
c a p i l l a ry length, to is the migration time of the electroosmotic
flow marker, and V is the applied voltage. The relative EOF can be
monitored using the values of to because all the other factors are
constant, as is evident from equation 1. In the studies reported
h e re, the values of to were measured with MeOH.
F i g u re 2 displays electrochromatograms for the separation of
benzodiazepines on a C18 s t a t i o n a ry phase using Tris–ACN
(40:60), Tris–MeOH (30:70), and Tris–THF (55:45) binary mixt u res. A reduction in electroosmotic mobility was observed from
1.78 × 10–4 for the ACN–buffer mixture to 4.64 × 10–5 cm2V–1s–1
for THF–buffer mixture. When the ACN–buffer mixture was
used, the total separation time decreased and peak efficiencies
i n c reased at the expense of lower resolution and retention factor
values. Using Tris–THF (55:45), the total separation was very
long and peak efficiencies were low. Although the analytes in the
m i x t u re were not well resolved using Tris–ACN (40:60), they
eluted in 20 min. Taking into consideration the peak efficiency
and speed of analysis, the Tris–ACN (40:60) binary mixture was
used to further optimize separation conditions for the benzodiazepines.
The retention mechanism of benzodiazepines on a C18 s t ationary phase with a mobile phase of ACN–H2O is based on the diff e rential partitioning of the analytes into the alkyl-bonded phase.
Their retention is determined by hydrophobic interactions
between the C18 stationaryphase and the nonpolar moiety of each
analyte and by interactions between the polar mobile phase and
sample molecules. The migration order of benzodiazepines for
the ACN–H 2O mobile phase was tR1,2< tR3,4< tR5< tR6< tR7.
However, the elution order changed when MeOH and THF were
used. The elution order for the MeOH–H2O mobile phase is tR3,4<
tR2< tR1< tR6< tR5< tR7 and tR1,2< tR5< tR6< tR3< tR4< tR7 for the
THF–H2O mobile phase.
Effect of mobile phase composition
In an attempt to achieve baseline separation, the content of
the aqueous buffer (10mM Tris, pH 8) was increased fro m
30% to 60%. As depicted in Figure 3, both selectivity and
retention time of the analytes increased with decreasing ACN
concentration. A decrease from 70% to 40% ACN increased
the selectivity between peaks 6 and 7 from 1.31 to 1.99. The
increase in selectivity is because of changes in the partition
coefficients as a result of the increased polarity of the mobile
phase. As the mobile phase became more polar, the analytes
partitioned more into the stationary phase, and they were
significantly retained. As a consequence of the latter, the
migration times were longer, resolution higher, and
efficiency lower. A slight increase in electroosmotic mobility,
at higher concentrations of ACN, was also observed from 1.57
× 10–4 to 3.56 × 10–4 cm2V–1s–1, probably because of an in the
ratio of the dielectric constant to buffer viscosity.
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Mobile phases comprised of Tris (10mM, pH 8) modified with
60%, 70%, and 45% of ACN, MeOH, or THF, respectively, were
used to study the influence of the modifier on the separations of
benzodiazepines. The organic solvent content was fixed in order
to have mobile phases with the same elution strength. A nomograph, which provides the interconversion of reversed-phase
mobile phases having the same strength, can be found elsewhere
(56,57). Ve rtical lines in this figure intersect mobile phases
having the same strength. For example, 70% MeOH has the same
s t rength as 60% ACN or 45% THF. The buffer Tris was chosen
because its low mobility would more closely match that of the
analytes when compared with more conventional buffers such as
borate and phosphate. The low mobility of Tris also allows higher
concentrations of buffer to be used without significantly
increasing the current. In addition, the relatively high ionic
s t rength of the buffer lead to sharper and more defined peaks. The
ionic strength of each mobile phase in this study was constant
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Effect of applied voltage

Effect of Tris concentration

The influence of the ionic strength of the mobile phase was also
evaluated using 10, 20, and 30mM Tris (pH 8)–ACN (60:40). At a
constant ACN content, as the ionic strength increased from 10 to
30mM, the retention time of the analytes increased (Figure 5). In
addition, the electroosmotic mobility decreased from 1.76 × 10–4
to 1.30 × 10–4 cm2V–1s–1 with increasing Tris concentration
because of the interactions of Tris with the silica interface, which

Figure 3. Effect of mobile phase composition on the CEC separation of benzodiazepines. Separation conditions are the same as in Figure 2, except the
mobile phase composition (ACN–Tris) was varied.

Figure 4. Effect of applied voltage on the CEC separation of benzodiazepines.
Separation conditions are the same as in Figure 2, except the applied voltage
was varied: electrolyte, 10mM Tris (pH 8)–ACN (60:40).

reduced the zeta potential. The electroosmotic mobility depended
on the zeta potential (z) as follows:
meo = eoezE/h

Eq. 2

where eo is the dielectric constant of free space, e is the dielectric
constant of the medium, E is the applied electric field strength,
and h is the viscosity of the medium. The zeta potential depended
on the buffer molar concentration (C) as follows (58):
z = σ(RT/2eoeCF2)1/2

Eq. 3

where σ is the surface excess charge density, R is the universal gas
constant, T is the absolute temperature, and F is the Faraday constant. According to equations 2 and 3, the electroosmotic

Figure 5. Effect of Tris concentration on the CEC separation of benzodiazepines. Separation conditions are the same as in Figure 2, except the Tris
buffer concentration was varied: electrolyte, Tris (pH 8)–ACN (60:40) and
applied voltage, 20 kV.

Figure 6. Effect of column temperature on the CEC separation of benzodiazepines. Separation conditions are the same as in Figure 2, except the temperature was varied: electrolyte, 30mM Tris (pH 8)–ACN (60:40) and applied
voltage, 20 kV.
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The effect of the applied voltage on the CEC separation of benzodiazepines was then investigated using a mobile phase of 10mM
Tris(pH 8)–ACN (60:40). As expected, retention times decreased
when a higher voltage was applied. Figure 4 demonstrates the
e l e c t ro c h romatograms obtained when 30, 20, and 15 kV were
applied. At 30 kV, the analytes eluted faster, with lower resolution
and higher efficiency. Although the resolution between analytes 2
and 6 was higher at 15 kV, the total separation time was longer.
Based on these results, 20 kV was applied to further optimize the
separation conditions.

Journal of Chromatographic Science, Vol. 42, May/June 2004

was able to be detected and separated from the other drugs. The
urine sample was injected at 15 kV for 5 s. Also proved was the
p resence of oxazepam in the urine sample by spiking with the
s t a n d a rd analyte (Figure 7B). For this experiment, the urine
sample was injected at 20 kV for 10 s and the standard analyte at
15 kV for 5 s.

Effect of column temperature

Conclusion

For this component of the study, the temperature was varied
from 45°C to 15°C, and the binary mixture 30mM Tris (pH
8)–ACN (60:40) was used as the mobile phase. As in CE, the elect roosmotic mobility increased upon increasing temperature in
CEC because of the decrease in viscosity of aqueous-organic solvent system. When the temperature increased from 15°C to 45°C,
the electroosmotic mobility increased from 1.24 × 10–4 to 1.82
10–4 cm2V–1s–1. As is also typical for LC, retention factors, retention times, and resolution decreased at higher temperatures. The
e ffects of these parameters by temperature variation are shown in
F i g u re 6. It is also shown that by decreasing the temperature to
15°C, all benzodiazepines were baseline resolved.
CEC separation of drugs from a urine sample

The sample used in this study was a urine calibrator that contained 1000 ng/mL oxazepam and other drugs, such as
acetaminophen, amphetamines, imipramine, morphine, cocaine,
etc. Without any sample preparation, the urine sample was
injected into the CEC capillary, and the optimum conditions were
applied. Figure 7A illustrates that the trace amount of oxazepam

A

In this study, a new CEC method for the baseline resolution of
benzodiazepines has been developed. The optimized method
proved to be effective in separating and identifying oxazepam in
urine samples that contain various concentrations of other drugs.
It is concluded that this CEC method is promising for determining benzodiazepines in forensic and clinical drug analysis
without any sample preparation. Also understood is how several
parameters affect the electrophoretic and separation mechanisms
of hydrophobic analytes on an ODS stationary phase. The volume
fraction of ACN and temperature were inversely proportional to
migration time and resolution. However, electroosmotic mobility
i n c reased upon increasing the volume fraction of ACN or tempera t u re. In contrast, the ionic strength of the electrolyte was proportional to the migration time and resolution and inversely
proportional to electroosmotic mobility. Finally, higher re s o l utions and good peak symmetries were obtained at 15°C when a
b i n a ry mixture of 30mM Tris (pH 8)–ACN (60:40) was used.
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